Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period

Transfusion

Volumn 42, Issue 9, 2002, Pages 1154-1158

  Herwaldt, Barbara L ^a,b,c   Neitzel, David F ^a,b,c   Gorlin, Jed B ^a,b,c   Jensen, Kathryn A ^a,b,c   Perry, Elizabeth H ^a,b,c   Peglow, William R ^a,b,c   Slemenda, Susan B ^a,b,c   Won, Kimberly Y ^a,b,c   Nace, Eva K ^a,b,c   Pieniazek, Norman J ^a,b,c   Wilson, Marianna ^a,b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c Ridgeview Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

AGED; ANIMAL; ARTICLE; BABESIA MICROTI; BABESIOSIS; BLOOD; BLOOD DONOR; CAMPING; CASE REPORT; CONTACT EXAMINATION; CORONARY ARTERY BYPASS GRAFT; DISEASE TRANSMISSION; ERYTHROCYTE TRANSFUSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART VALVE REPLACEMENT; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PARASITEMIA; PARASITOLOGY; POSTOPERATIVE COMPLICATION; THROMBOCYTE TRANSFUSION; UNITED STATES;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; BABESIA MICROTI; BABESIOSIS; BLOOD DONORS; CAMPING; CONTACT TRACING; CORONARY ARTERY BYPASS; DISEASE TRANSMISSION, HORIZONTAL; ERYTHROCYTE TRANSFUSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PARASITEMIA; PLATELET TRANSFUSION; POSTOPERATIVE COMPLICATIONS;

EID: 18744387006     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00189.x     Document Type: Article

References (20)

1. 1 Herwaldt BL, Springs FE, Roberts PP, et al. Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg 1995 ; 53: 146 ‐ 51.
2. 2 Steketee RW, Eckman MR, Burgess EC, et al. Babesiosis in Wisconsin: a new focus of disease transmission. JAMA 1985 ; 253: 2675 ‐ 8.
3. 3 Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996 ; 34: 724 ‐ 7.
4. 4 White DJ, Talarico J, Chang H, et al. Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998 ; 158: 2149 ‐ 54.
5. 5 Hatcher JC, Greenberg PD, Antique J, Jimenez‐Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001 ; 32: 1117 ‐ 25.
6. 6 Meldrum SC, Birkhead GS, White DJ, et al. Human babesiosis in New York state: an epidemiological description of 136 cases. Clin Infect Dis 1992 ; 15: 1019 ‐ 23.
7. 7 Cable RG, Trouern‐Trend J. Tickborne infections. In: Linden JV, Bianco C, editors. Blood safety and surveillance. New York: Marcel Dekker; 2001:399‐422.
8. 8 Eberhard ML, Walker EM, Steurer FJ. Survival and infectivity of Babesia in blood maintained at 25°C and 2‐4°C. J Parasitol 1995 ; 81: 790 ‐ 2.
9. 9 McQuiston JH, Childs JE, Chamberland ME, Tabor E. Transmission of tick‐borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000 ; 40: 274 ‐ 84.
10. 10 Gerber MA, Shapiro ED, Krause PJ, et al. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis 1994 ; 170: 231 ‐ 4.
11. 11 Reddy RL, Dalmasso AP. Transfusion acquired babesiosis in Minnesota (abstract). In: ISBT and AABB 1990 joint congress abstract book. Arlington: American Association of Blood Banks; 1990:112.
12. 12 Chisholm ES, Ruebush TK 2nd, Sulzer AJ, Healy GR. Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 1978 ; 27: 14 ‐ 9.
13. 13 Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: a new species of Babesia ? Ann Intern Med 1993 ; 119: 284 ‐ 90.
14. 14 Persing DH, Mathiesen D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992 ; 30: 2097 ‐ 103.
15. 15 Office of Laboratory Animal Welfare. Public Health Service policy on humane care and use of laboratory animals. 2000 Oct. Available from: http://grants.nih.gov/grants/olaw/references/phspol.htm.
16. 16 Matuschka FR, Spielman A. Risk of infection from and treatment of tick bite. Lancet 1993 ; 342: 529 ‐ 30.
17. 17 Leiby DA, Chung APS, Cable RG, et al. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila in blood donors. Transfusion 2002 (in press).
18. 18 Popovsky MA, Lindberg LE, Syrek AL, Page PL. Prevalence of Babesia antibody in a selected blood donor population. Transfusion 1988 ; 28: 59 ‐ 61.
19. 19 Krause PJ, Spielman A, Telford SR 3rd, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998 ; 339: 160 ‐ 5.
20. 20 Herwaldt BL, Kjemtrup AM, Conrad PA, et al. Transfusion‐transmitted babesiosis in Washington State: first reported case caused by a WA1‐type parasite. J Infect Dis 1997 ; 175: 1259 ‐ 62.